86 related articles for article (PubMed ID: 3249659)
1. Serum type-III-procollagen and laminin concentration after interferon therapy in chronic myeloproliferative disorders.
Sréter L; Kárteszi M; Fehér J; Lutz D
Acta Med Hung; 1988; 45(3-4):323-8. PubMed ID: 3249659
[TBL] [Abstract][Full Text] [Related]
2. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
4. [Laminin P1 and procollagen III peptide in serum: activity parameters in chronic inflammatory joint diseases].
Schneider M; Lohmann J; Gerlach U
Z Rheumatol; 1988; 47(2):93-7. PubMed ID: 3388992
[TBL] [Abstract][Full Text] [Related]
5. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
7. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.
Heikius B; Niemelä O; Niemelä S; Karttunen TJ; Lehtola J
Hepatogastroenterology; 2002; 49(44):404-11. PubMed ID: 11995461
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of extracellular matrix in acute pancreatitis.
Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S
Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
Gressner AM; Tittor W; Negwer A
Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
[TBL] [Abstract][Full Text] [Related]
11. [Parameters of connective tissue metabolism as markers in acute and chronic pancreatitis. A retrospective study with a cohort of normal subjects].
Löhr M; Spies B; Heptner G; Domschke S; Hahn EG
Z Gastroenterol; 1991 May; 29(5):231-6. PubMed ID: 1950031
[TBL] [Abstract][Full Text] [Related]
12. Early decrease in serum IV-7S levels during IFN treatment predicts anti-fibrogenic effect in nonresponders with chronic hepatitis C.
Abe S; Narita R; Hiura M; Jia DM; Tabaru A; Otsuki M
J Gastroenterol; 2004; 39(3):247-54. PubMed ID: 15065002
[TBL] [Abstract][Full Text] [Related]
13. Serum laminin P1 in idiopathic myelofibrosis and related diseases.
Hasselbalch H; Junker P
Leuk Res; 1994 Aug; 18(8):623-8. PubMed ID: 8065164
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
15. [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].
Linkesch W; Gisslinger H; Ludwig H; Flener R; Sinzinger H
Acta Med Austriaca; 1985; 12(5):123-7. PubMed ID: 3914173
[TBL] [Abstract][Full Text] [Related]
16. [Markers of hepatic fibrogenesis in alcoholic patients].
de la Maza MP; Chichester C; Hirsch S; Petermann M; Iturriaga H; Bunout D
Rev Med Chil; 1997 Jan; 125(1):15-21. PubMed ID: 9336064
[TBL] [Abstract][Full Text] [Related]
17. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of determining the amino terminal fragment of procollagen III in myeloproliferative disorders].
Najean Y; Poirier O; Arrago JP
Nouv Rev Fr Hematol (1978); 1987; 29(2):123-7. PubMed ID: 3615194
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
20. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man.
Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J
Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
